Debevoise Advises Carlyle in Its Strategic Partnership with Orsini and Consonance Capital Partners

11 February 2022

Debevoise & Plimpton LLP is advising Carlyle (NASDAQ: CG) in its strategic partnership with Orsini Specialty Pharmacy the leading independent specialty pharmacy focused on rare diseases, gene therapies and complex conditions, along with Consonance Capital Partners. The deal is set to further expand patient access to therapies that treat rare diseases and chronic conditions. Terms of the transaction were not disclosedFor more information, please read the company’s press release.

The Debevoise team is led by M&A partner Spencer Gilbert and includes partner Kevin Rinker, counsel Kim Le and associates Mihai Chitulescu, Tiancheng (TC) Huang, Hannah Levine, Elina Sigal and Sergio Torres and law clerk Candice Jones, finance partner Ryan Rafferty and associates Alexandra Grossman and Max Lovrin, benefits counsel Kathleen Emberger and associate Spencer Mizerak, tax partner Peter Furci and associate Jay Evans, intellectual property counsel Caroline Geiger, associate Melody Godbolt and law clerk Moses Kim, FDA regulatory partner Paul Rubin and associate Melissa Runsten, antitrust partner Michael Schaper, counsel Kyra Bromley and associate William Dolan, litigation counsel Jacob Stahl and associate Adam Aukland-Peck and environmental counsel Stuart Hammer.